EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links

EndoTODAY ³»½Ã°æ ±³½Ç


[StomachTODAY 051. Inflammatory myofibroblastic tumor (IMT)]

Previous | Next

°Ç°­°ËÁø ³»½Ã°æ¿¡¼­ ¹ß°ßµÈ Á¡¸·ÇÏÁ¾¾çÀ¸·Î ÀÇ·ÚµÈ ºÐÀÌ´Ù. Å©±â´Â 15mm Á¤µµ·Î ÃßÁ¤µÇ¾úÀ¸¸ç Ç¥¸éÀº ¹ßÀûµÇ¾î ÀÖ¾úÀ¸¸ç 4 ¹æÇâ¿¡¼­ bridging fold°¡ ¸ðÀÌ´Â ¾ç»óÀ̾ú°í Á¶Á÷°Ë»ç¿¡¼­´Â ƯÀ̼ҰßÀÌ ¾ø¾ú´Ù. ¹ß¿­À̳ª üÁß°¨¼Ò, ÇǷΰ¨ µî Àü½ÅÁõ¼¼´Â ¾ø¾ú´Ù.

CT¸¦ ½ÃÇàÇÏ¿´´Ù. À§Ã¼»óºÎ ´ë¸¸ Èĺ®Ãø¿¡ 1.9 cm±îÁö ÃøÁ¤µÇ´Â hyperdenseÇÑ ³­Çü º´¼Ò°¡ °üÂûµÇ¾ú°í GIST ȤÀº ´Ù¸¥ Á¾·ùÀÇ Ç÷°ü°ú´ÙÁ¾±«·Î ÃßÁ¤µÇ¾ú´Ù.

º¹°­°æ ½û±â ÀýÁ¦¼úÀÌ ½ÃÇàµÇ¾ú´Ù. º´¸® ¼Ò°ß¿¡¼­ ¹æÃßÇü ¼¼Æ÷°¡ ¼Ò¿ëµ¹ÀÌ ¸ð¾çÀ» ÀÌ·ç°í ÀÖ°í ¿°Áõ¼¼Æ÷ÀÇ Ä§À±ÀÌ µ¿¹ÝµÇ¾î ÀÖ¾ú´Ù. Actin ¾ç¼º, CD23 À½¼º, ALL À½¼º, Kappa¿Í Lambda´Â polyclonalÇÏ°Ô ¾ç¼ºÀ̾ú´Ù. ¿°Áõ¼º ±Ù¼¶À¯¸ð¼¼Æ÷¼º Á¾¾ç (Inflammatory myofibroblastic tumor IMT)À¸·Î Áø´ÜµÇ¾ú´Ù. 1³â ÈÄ ÃßÀû°Ë»ç¿¡¼­ Àç¹ß ¼Ò°ßÀÌ ¾ø¾ú´Ù.

¿°Áõ¼º ±Ù¼¶À¯¸ð¼¼Æ÷¼º Á¾¾ç (IMT)´Â °ú°Å¿¡´Â ¹ÝÀÀ¼º º¯È­·Î »ý°¢ÇÏ¿© inflammatory myofibrohistiocytic proliferation, inflammatory pseudotumor µîÀ¸·Î ºÒ¸®¿üÀ¸³ª ÀÌÁ¦´Â Á¾¾ç¼ºÀ¸·Î °£ÁֵǾî IMT·Î ºÒ¸®´Â Á¾¾çÀÌ´Ù. ¼Ò¾Æ, HIV °¨¿°, ¸¸¼º À°¾ÆÁ¾¼º Áúȯ¿¡¼­ ÈçÇϸç EBV³ª HHV-8 °¨¿°°ú °ü·ÃµÈ´Ù´Â ÁÖÀåÀÌ ÀÖ´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ±Ù¼¶À¯¸ð¼¼Æ÷ÀÇ Áõ½Ä°ú ÇüÁú¼¼Æ÷, ¸²ÇÁ±¸ ¹× Á¶Á÷±¸°¡ ÇÔ²² ÃâÇöÇÑ´Ù. ALK gene rearrangement°¡ 50%¿¡¼­ ¹ß°ßµÈ´Ù. Æó¿¡ ¹ß»ýÇÏ´Â °æ¿ì°¡ °¡Àå ¸¹À¸¸ç º¹ºÎ, Èĺ¹¸·, ¾È¿Í, °æºÎ, ÁßÃ߽Űæ°è µî ¾îµð¿¡¼­³ª ¹ß»ýÇÒ ¼ö ÀÖ´Ù. À§Àå°ü¿¡¼­´Â º¹Åë, º¹ºÎ Á¾±«, ¼³»ç, ÀåÆó»ö µîÀÇ Áõ»óÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Ù. ¹ß¿­, night sweat, üÁß°¨¼Ò, ÇǷΰ¨ µîÀÇ Àü½Å Áõ»óÀ» µ¿¹ÝÇÒ ¼ö ÀÖ´Ù. ¿ì¸®³ª¶ó¿¡¼­´Â ¹«Áõ»ó ¼ºÀο¡¼­ ¹ß°ßµÉ ¼ö ÀÖ´Ù. ¼ö¼úÀû ÀýÁ¦°¡ ¿øÄ¢ÀÌ¸ç ¨ù¿¡¼­ ±¹¼ÒÀç¹ßÀ» ÇÏ¸ç µå¹°°Ô ÀüÀ̸¦ º¸ÀÏ ¼ö ÀÖ´Ù. ±¹¼ÒÀç¹ß º´¼Ò¿¡ ´ëÇؼ­´Â Ãß°¡ÀûÀÎ ÀýÁ¦¼úÀ» ½ÃÇàÇÑ´Ù.


[More cases]

20´ë ¿©¼ºÀÌ Ç㸮 ÅëÁõÀ¸·Î ½ÃÇàÇÑ spine MRI¿¡¼­ mass°¡ ¹ß°ßµÇ¾ú½À´Ï´Ù (MRI Æǵ¶: L1-2 levelÀÇ aortocaval area·Î 7.7 x 6.3 cmÀÇ solid mass·Î »ý°¢µÇ´Â retroperitoneal mass). Àú´Â lymphomaÀÇ °¡´É¼ºÀÌ Å©Áö ¾Ê³ª »ý°¢ÇÏ¿´Áö¸¸ stomach CT¿¡¼­´Â ¡°Primary retroperitoneal mass such as neurogenic tumor, more likely¡±¶ó´Â impression°ú ÇÔ²² massÀÇ T2 signalÀÌ ³ô°í ºÒ±ÕÁúÇÏ¸ç ³»ºÎ¿¡ calcificationÀÌ ÀÖ´Â Á¡Àº ÀüÇüÀûÀÎ lymphoma¿Í´Â ¸ÂÁö ¾Ê´Â ¼Ò°ßÀ̶ó´Â ÀÇ°ßÀ» ¾ò¾ú½À´Ï´Ù. ³»½Ã°æ¿¡¼­´Â À§Ã¼ºÎÀÇ extrinsic compressionÀ¸·Î °üÂûµÇ¾ú½À´Ï´Ù. ¼ö¼úÀ» ½ÃÇàÇÏ¿´°í inflammatory myofibroblastic tumor (IMT)¶ó´Â ÃÖÁ¾ Áø´ÜÀ» ¹Þ¾Ò½À´Ï´Ù. IMT´Â intermediate biologic potentialÀ» °¡Áö´Â neoplasmÀ¸·Î Âü°í ¹®ÇåÀÇ ÀϺθ¦ ¼Ò°³ÇÑ´Ù.

Coffin CM, et al. Semin Diagn Pathol 1998;15:85-101. IMT or inflammatory pseudotumor was initially recognized in the lung, and somewhat later, a similar-appearing pathological process was reported in the liver. Presently, this tumor has been described in virtually all major organs and extrapulmonary sites with a few exceptions. It was thought initially that the IMT was nonneoplastic and represented an aberrant inflammatory response despite its gross and microscopic features of a spindle cell neoplasm. The inflammatory hypothesis about the pathogenesis has been more readily accommodated in the lung than in the extrapulmonary sites of involvement. Some cases, however, were accompanied by the constitutional symptoms and signs of an inflammatory process, which resolved in most cases after surgical resection. There were some pathological aspects of the IMT that seemingly contradicted its purely inflammatory nature, including its potential for local recurrence; development of multifocal, noncontiguous tumors; infiltrative local growth; vascular invasion; and malignant transformation. These pathological features seemed to support the hypothesis that the IMT is a neoplastic process, which has been augmented by reports that these tumors have clonal characteristics. Because these tumors have a predilection for children, embryonal rhabdomyosarcoma is another diagnostic temptation when an IMT presents in the bladder or other hollow viscus.


[References]

1) EsoTODAY - ½ÊÀÌÁöÀåÁúȯ Áõ·ÊÅäÀÇ

2) SmallTODAY - ¼ÒÀåÁúȯ Áõ·ÊÅäÀÇ

3) ColonTODAY - ´ëÀåÁúȯ Áõ·ÊÅäÀÇ

4) Dr. Sinn's LiverTODAY - °£Áúȯ Áõ·ÊÅäÀÇ

5) ½ÊÀÌÁöÀå¿¡¼­ ¹ß»ýÇÑ ¿°Áõ¼º ±Ù¼¶À¯¸ð¼¼Æ÷Á¾ 1¿¹ Korean J Gastroenterol 2018;72:28-32 (ºÎ»ê´ë Áõ·Ê)

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng (2022-7-30, update: 2024-8-16)